Fulcrum Therapeutics, Inc.·4

Jun 29, 4:16 PM ET

Morabito Christopher 4

4 · Fulcrum Therapeutics, Inc. · Filed Jun 29, 2021

Insider Transaction Report

Form 4
Period: 2021-06-28
Morabito Christopher
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2021-06-28$9.16/sh+1,100$10,0761,100 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION